This was demonstrated in an in vivo mouse model where the NC1 (XIX) peptide inhibited tumor growth, and where the NC1 (XIX) peptide inhibited angiogenesis by matrix metalloproteinase-14 and vascular endothelial growth factor inhibition [23]. Here, VEGFA is linked to neoplasm.